Pharmanutra S.p.A. (BIT: PHN)
Italy
· Delayed Price · Currency is EUR
50.90
+0.10 (0.20%)
Jan 31, 2025, 5:35 PM CET
Pharmanutra Revenue
Pharmanutra had revenue of 27.44M EUR in the quarter ending September 30, 2024, with 25.18% growth. This brings the company's revenue in the last twelve months to 113.13M, up 19.63% year-over-year. In the year 2023, Pharmanutra had annual revenue of 101.03M with 21.64% growth.
Revenue (ttm)
113.13M
Revenue Growth
+19.63%
P/S Ratio
4.34
Revenue / Employee
950.63K
Employees
105
Market Cap
489.04M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 101.03M | 17.97M | 21.64% |
Dec 31, 2022 | 83.06M | 14.92M | 21.89% |
Dec 31, 2021 | 68.14M | 11.38M | 20.04% |
Dec 31, 2020 | 56.77M | 3.10M | 5.78% |
Dec 31, 2019 | 53.67M | 6.87M | 14.67% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Recordati Industria Chimica e Farmaceutica | 2.27B |
Amplifon | 2.36B |
DiaSorin | 1.18B |
EL.En. | 665.50M |
Philogen | 3.92M |
Garofalo Health Care | 450.33M |
Safilo Group | 1.01B |
GPI S.p.A. | 484.01M |